172
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Case Report: Retinal Vasculitis in Two Adolescents After COVID-19 Vaccination

, FRCOphth FRCSEd(Ophth), , FRCP FRCOphth, , FRCOphth FCOphthHK, , FCOphthHK FHKAM, , FCOphthHK FHKAM, , FCOphthHK FHKAM & , MBBS MRCSEd(Ophth) show all
Pages 1245-1249 | Received 11 May 2022, Accepted 20 Sep 2022, Published online: 13 Oct 2022

References

  • Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369(6499):77–81. doi:10.1126/science.abc1932.
  • Xia S, Zhang Y, Wang Y, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomized, double-blind, placebo-controlled, phase ½ trial. Lancet Infect Dis. 2021;31(1):39–51. doi:10.1016/S1473-3099(20)30831-8.
  • Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.CoV2.S vaccine against COVID-19. N Engl J Med. 2021;384(23):2187–2201. doi:10.1056/NEJMoa2101544.
  • Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised trials in Brazil, South Africa, and the UK. Lancet. 2021;397(23):99–111. doi:10.1016/S0140-6736(20)32661-1.
  • Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Eng J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577.
  • Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Eng J Med. 2021;384(5):403–416. doi:10.1056/NEJMoa2035389.
  • Heath PT, Galiza EP, Baxter DN, et al. Safety and efficacy of NVX-CoV2373 COVID-19 vaccine. N Eng J Med. 2021;385(13):1172–1183. doi:10.1056/NEJMoa2107659.
  • Bolletta E, Iannetta D, Mastrofilippo V, et al. Uveitis and other complications following COVID-19 vaccination. J Clinical Med. 2021;10(24):5960. doi:10.3390/jcm10245960.
  • Goyal M, Murthy SI, Annum S. Bilateral multifocal choroiditis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(4):753–757. doi:10.1080/09273948.2021.1957123.
  • Jampol LM, Tauscher R, Schwartz HP. COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina: causation or coincidence? JAMA Ophthalmol. 2021;139(10):1135–1136. doi:10.1001/jamaophthalmol.2021.3483.
  • Bialasiewicz AA, Farah-Diab MS, Mebarki HT. Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine. Int Ophthalmol. 2021;41(12):3889–3892. doi:10.1007/s10792-021-01971-2.
  • Sacconi R, Simona F, Forte P, Querques G. Retinal vein occlusion following two doses of mRNA-1237 (Moderna) immunization for SARS-CoV-2: a case report. OphthalmolTher. 2022;11:453–458.
  • Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet. 2021;397(10285):e11. doi:10.1016/S0140-6736(21)00872-2.
  • Panovska-Stravridis I, Pivkova-Veljanovska A, Trajkova S, Lazarevska M, Grozdanova A, Filipche V. A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-19. Mediterr J Hematol Infect Dis. 2021;13(1):e2021048. doi:10.4084/MJHID.2021.048.
  • Erdem S, Karaham M, Dursun ME, et al. Retinal vasculitis case developing in the early period after COVID-19. Klin Morbl Augenheikd. 2021;239(9):1132–1133. doi:10.1055/a-1363-1326.
  • Insausti-Garcia A, Reche-Sainz JA, Ruiz-Arranz C, Lopez Vazquez A, Ferro-Osuna M. Papillophlebitis in a COVID-19 patient: inflammation and hypercoagulable state. Eur J Ophthalmol. 2020;32(1): NP168–NP172. doi:10.1177/1120672120947591.
  • Bostan E, Gulseren D, Gokoz O. New-onset leukocytoclastic vasculitis after COVID-19 vaccine. Int J Dermatol. 2021;60(10):1305–1306. doi:10.1111/ijd.15777.
  • Kar BR, Singh BS, Mohapatra L, Agrawal I. Cutaneous small-vessel vasculitis following COVID-19 vaccine. J Cosmet Dermatol. 2021;20(11):3382–3383. doi:10.1111/jocd.14452.
  • Dash S, Behera B, Sethy M, Mishra J, Garg S. COVID-19 vaccine-induced urticarial vasculitis. Dermatol Ther. 2021;34(5):e15093. doi:10.1111/dth.15093.
  • Gillion V, Jadoul M, Demoulin N, Aydin S, Devresse A. Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine. Kidney Int. 2021;100(3):706–707. doi:10.1016/j.kint.2021.06.033.
  • Shakoor MT, Birkenbach MP, Lynch M. ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis. 2021;78(4):611–613. doi:10.1053/j.ajkd.2021.06.016.
  • Tagini F, Carrel L, Fallet B, Gachoud D, Ribi C, Monti M. Behcet’s-like adverse event or inaugural Behcet’s disease after SARS-CoV-2 mRNA-1273 vaccination? Rheumatology. 2021;61(5):e112–e1123. doi:10.1093/rheumatology/keab751.
  • Hashizume H, Ajima S, Ishikawa Y. Emergence of Behcet’s disease post-SARS-CoV2-vaccination: two clinical case in Japan. J Eur Acad Dermatol Vernereol. 2022;36(4):e248–e249. doi:10.1111/jdv.17859.
  • Cohen SR, Prussick L, Kahn JS, Gao DX, Radfar A, Rosmarin D. Leukocytoclastic vasculitis flare following the COVID-19 vaccine. Int J Dermatol. 2021;60(8):1032–1033. doi:10.1111/ijd.15623.
  • Kwok T, Al-Bermani A. Two rare cases of retinal vasculitis following vaccination. Scott Med J. 2013;58(2):e10–e12. doi:10.1177/0036933013482660.
  • Williams GS, Evans S, Yeo D, Al-Bermani A. Retinal artery vasculitis secondary to administration of influenza vaccine. BMJ Cas Rep. 2015;bcr2015211971. doi:10.1136/bcr-2015-211971.
  • Bonetto C, Trotta F, Felicetti P, et al. Vasculitis as an adverse event following immunization- systematic literature review. Vaccine. 2016;34(51):6641–6651. doi:10.1016/j.vaccine.2015.09.026.
  • Watanabe T. Vasculitis following influenza vaccination: a review of the literature. CRR. 2017;13(3):3. doi:10.2174/1573397113666170517155443.
  • Hebert M, Couture S, Schmit I. Bilateral panuveitis with occlusive vasculitis following coronavirus disease 2019 vaccination. Ocular Immunol Inflamm. 2022;1–5. doi:10.1080/09273948.2022.2042325.
  • Ali A, Ku JH, Suhler EB, Choi D, Rosenbaum JT. The course of retinal vasculitis. Br J Ophthalmol. 2014;98(6):785–789. doi:10.1136/bjophthalmol-2013-303443.
  • RC B. COVID-19 associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020;50(3):499–511. doi:10.1007/s11239-020-02230-4.
  • Becker R. COVID-19 update: COVID-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50(1):54–67. doi:10.1007/s11239-020-02134-3.
  • Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147. doi:10.1016/j.thromres.2020.04.013.
  • Vodjani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480. doi:10.1016/j.clim.2020.108480.
  • Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009;5(11):648–652. doi:10.1038/nrrheum.2009.196.
  • Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol. 2018;15(6):586–594. doi:10.1038/cmi.2017.151.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.